Pharmaroth Interest Expense from 2010 to 2025
| ROTH Stock | USD 0.0001 0.00 0.00% |
Interest Expense | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Pharmaroth Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmaroth Labs' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 154.1 K or Total Revenue of 219.2 K, as well as many indicators such as Price To Sales Ratio of 10.56, Dividend Yield of 0.0 or Days Sales Outstanding of 193. Pharmaroth financial statements analysis is a perfect complement when working with Pharmaroth Labs Valuation or Volatility modules.
Pharmaroth | Interest Expense | Build AI portfolio with Pharmaroth Stock |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Pharmaroth Labs Correlation against competitors. For more detail on how to invest in Pharmaroth Stock please use our How to Invest in Pharmaroth Labs guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmaroth Labs. If investors know Pharmaroth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmaroth Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmaroth Labs is measured differently than its book value, which is the value of Pharmaroth that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmaroth Labs' value that differs from its market value or its book value, called intrinsic value, which is Pharmaroth Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmaroth Labs' market value can be influenced by many factors that don't directly affect Pharmaroth Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmaroth Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmaroth Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmaroth Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.